Chlordiazepoxide Hydrochloride And Clidinium Bromide
Product Images NDC 69189-0489

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hydrochloride And Clidinium Bromide (NDC 69189-0489). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avera Mckennan Hospital, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chlordiazepoxide/clidinium 5/2.5 mg Capsule (6918904891)

Label for Chlordiazepoxide and Clidinium Bromide 5 mg / 2.5 mg capsules. The label indicates manufacturing by Oceanside, with lot numbers and an expiration date of 01/17/2017. The product is labeled by Avera McKennan Hospital, Sioux Falls, SD, and includes the NDC number 69189-0489.*

FDA Label Image

Chmical Structure (Chlordiazepoxide 01)

Chemical structure diagram showing the molecular structure of Chlordiazepoxide Hydrochloride with its atomic symbols and bonds clearly depicted.*

FDA Label Image

Chmical Structure (Chlordiazepoxide 02)

Chemical structure diagram of the active ingredient Clidinium Bromide as part of the product Chlordiazepoxide Hydrochloride and Clidinium Bromide. The diagram shows the molecular arrangement including aromatic rings and bromide ion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.